Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.
MacLeod
A M
AM
Chemistry Department, Merck, Sharp and Dohme Research Laboratories, Harlow, Essex, U.K.
Street
L J
LJ
Reeve
A J
AJ
Jelley
R A
RA
Sternfeld
F
F
Beer
M S
MS
Stanton
J A
JA
Watt
A P
AP
Rathbone
D
D
Matassa
V G
VG
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D008881:Migraine Disorders / Q000188:drug therapy*; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin / Q000187:drug effects*; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D013045:Species Specificity
D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists